Senti Biosciences Holdings, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
0.3948
+0.0247 (6.67%)
Aug 4, 2026, 1:12 PM EDT - Market open
SNTI Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.02 | 0.02 | - | 2.56 | 4.29 | 2.76 | |
Revenue Growth | - | - | - | -40.25% | 55.23% | 387.81% |
Gross Profit | 0.02 | 0.02 | - | 2.56 | 4.29 | 2.76 |
Selling, General & Admin | 25.28 | 26.16 | 26.37 | 37.18 | 38.23 | 21.25 |
Research & Development | 33.59 | 37.59 | 34.36 | 32.15 | 28.15 | 21.96 |
Other Operating Expenses | 6.88 | 5.05 | 0.31 | 25.96 | - | -0.02 |
Total Operating Expenses | 65.75 | 68.8 | 61.04 | 95.29 | 66.37 | 43.19 |
Operating Income | -57 | -68.78 | -61.04 | -92.73 | -62.08 | -40.45 |
Interest Income | 0.63 | 0.93 | 0.95 | 2.86 | 1.7 | 0.01 |
Other Non-Operating Income (Expense) | 4.66 | 6.41 | 7.3 | 6.46 | 10.72 | -14.86 |
Total Non-Operating Income (Expense) | 5.29 | 7.34 | 8.25 | 9.32 | 12.42 | -14.85 |
Pretax Income | -51.71 | -61.44 | -52.79 | -83.41 | -49.67 | -55.3 |
Net Income | -51.71 | -61.44 | -52.79 | -83.41 | -49.67 | -55.3 |
Earnings From Discontinued Operations | - | - | - | 12.35 | -8.55 | - |
Net Income to Common | -51.55 | -61.44 | -52.79 | -71.06 | -58.21 | -55.32 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 28 | 22 | 5 | 4 | 3 | 0 |
Shares Outstanding (Diluted) | 28 | 22 | 5 | 4 | 3 | 0 |
Shares Change | 364.51% | 389.20% | 3.58% | 69.93% | 796.58% | -79.92% |
EPS (Basic) | -1.92 | -2.73 | -12.03 | -18.80 | -22.30 | -190.00 |
EPS (Diluted) | -1.92 | -2.73 | -12.03 | -18.80 | -22.30 | -190.00 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -36.88 | -43.64 | -41.42 | -64.43 | -76.27 | -40.18 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -1.33 | -1.94 | -9.01 | -14.52 | -29.21 | -137.96 |
Gross Margin | 100.00% | 100.00% | - | 100.00% | 100.00% | 100.00% |
Operating Margin | -356238.00% | -312632.00% | - | -3620.73% | -1448.53% | -1464.90% |
Profit Margin | -323169.00% | -279264.00% | - | -3256.77% | -1158.77% | -2002.79% |
FCF Margin | -230469.00% | -198364.00% | - | -2515.93% | -1779.51% | -1455.20% |
EBITDA | -53.6 | -65.14 | -57.2 | -87.3 | -58.16 | -37.44 |
EBITDA Margin | -334994.00% | -296100.00% | - | -3408.75% | -1357.07% | -1355.89% |
EBIT | -57 | -68.78 | -61.04 | -92.73 | -62.08 | -40.45 |
EBIT Margin | -356238.00% | -312632.00% | - | -3620.73% | -1448.53% | -1464.90% |